SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-205262
Filing Date
2023-08-08
Accepted
2023-08-07 21:51:27
Documents
3
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A d520772dpre14a.htm PRE 14A 869164
2 GRAPHIC g520772g00a02.jpg GRAPHIC 55749
3 GRAPHIC g520772g00a56.jpg GRAPHIC 692386
  Complete submission text file 0001193125-23-205262.txt   1892144
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37722 | Film No.: 231149125
SIC: 2834 Pharmaceutical Preparations